Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Fate Therapeutics, Inc.    FATE

FATE THERAPEUTICS, INC.

(FATE)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Upcoming events on FATE THERAPEUTICS, INC.
03/08/21 FY 2020 Earnings Release (Projected)
05/13/21 Q1 2021 Earnings Release (Projected)
08/11/21 Interim 2021 Earnings Release (Projected)
11/09/21 Q3 2021 Earnings Release (Projected)
Past events on FATE THERAPEUTICS, INC.
12/05/20 American Society of Hematology Meeting
12/04/20 | 09:30pm Business Update Call
12/01/20 | 08:30pm Evercore ISI HealthCONx Conference
11/19/20 | 02:05pm Jefferies Healthcare Conference
Upcoming sector events for FATE THERAPEUTICS, INC.
01/27/21 GALAPAGOS NV : Degroof Petercam Healthcare Conference
01/27/21 LONZA GROUP LTD : FY 2020 Earnings Release
01/27/21 | 08:30am LONZA GROUP LTD : FY 2020 Earnings Call
01/31/21 TURNING POINT THERAPEUTICS, INC. : Lung Cancer World Conference
More events
Past sector events for FATE THERAPEUTICS, INC.
01/21/21 | 10:30pm BIOCON LIMITED : Q3 2021 Earnings Call
01/21/21 SHANGHAI RAAS BLOOD PRODUCTS CO., LTD. : Extraordinary Shareholders Meeting
01/21/21 BIOCON LIMITED : Q3 2021 Earnings Release
01/20/21 | 01:00pm IOVANCE BIOTHERAPEUTICS, INC. : B. Riley Oncology Investor Conference
Annual publications
Annual results201520162017201820192020 (e)
Sales
M $
Released
Forecast
Spread
2,43
2,03
20%
4,40
4,35
1,1%
4,11
4,02
2,2%
4,74
4,08
16%
10,7
9,62
11%

20,6
Operating income
(EBITDA)
M $
Released
Forecast
Spread
-27,8
-28,2
1,4%
-32,0
-33,1
3,5%
-42,1
-40,8
-3,3%
-67,1
-65,9
-1,7%
-101
-99,9
-0,82%

-130
Operating profit
(EBIT)
M $
Released
Forecast
Spread
-30,0
-30,3
1,2%
-33,5
-34,9
4,1%
-43,0
-41,5
-3,4%
-66,6
-65,6
-1,5%
-98,1
-97,4
-0,72%

-145
Pre-Tax Profit
(EBT)
M $
Released
Forecast
Spread
-30,0
-30,3
1,2%
-33,5
-35,0
4,3%
-43,0
-41,6
-3,3%
-66,6
-66,0
-0,98%
-98,1
-97,8
-0,40%

-146
Net income
$
Released
Forecast
Spread
-1,18
-1,19
0,51%
-1,05
-1,14
7,5%
-1,02
-0,97
-5,2%
-1,19
-1,18
-0,73%
-1,44
-1,44
0,21%

-1,81
Announcement Date03/03/201603/16/201703/05/201803/05/201903/02/2020

Quarterly publications
Previous periodNext period
Quarterly results2019 Q32019 Q42020 Q12020 Q22020 Q32020 Q4 (e)
Sales
M $
Released
Forecast
Spread
2,43
1,75
38%
2,80
1,70
65%
2,52
1,69
49%
5,47
10,9
-50%
7,56
7,49
0,90%

5,06
Operating income
(EBITDA)
M $
Released
Forecast
Spread
-27,1
-25,6
-6,1%
-29,1
-28,3
-2,6%
-34,5
-30,1
-15%
-28,7
-22,3
-29%
-31,5
-28,3
-11%

-35,0
Operating profit
(EBIT)
M $
Released
Forecast
Spread
-26,6
-25,3
-5,0%
-28,3
-27,9
-1,3%
-33,5
-29,7
-13%
-28,1
-21,1
-33%
-58,7
-27,2
-116%

-33,1
Pre-Tax Profit
(EBT)
M $
Released
Forecast
Spread
-26,6
-25,5
-4,5%
-28,3
-28,2
-0,23%
-33,5
-29,3
-15%
-28,1
-21,6
-30%
-58,7
-27,2
-116%

-33,5
Net income
$
Released
Forecast
Spread
-0,40
-0,38
-5,3%
-0,37
-0,39
4,9%
-0,44
-0,39
-13%
-0,35
-0,29
-22%
-0,68
-0,32
-110%

-0,39
Announcement Date11/05/201903/02/202005/11/202008/05/202011/05/2020

Financial data source
© 2021 S&P Global Market Intelligence
© 2021 Factset
Net sales (Year) - Rate of surprise
EPS (Year) - Rate of surprise
Net sales (Quarter) - Rate of surprise
EPS (Quarter) - Rate of surprise